{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:15:26Z","timestamp":1791850526771,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6580,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1093\/annonc\/mdf002","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:59:57Z","timestamp":1027724397000},"page":"150-156","source":"Crossref","is-referenced-by-count":111,"title":["Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type"],"prefix":"10.1016","volume":"13","author":[{"given":"K.-F.","family":"Foo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.-H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-S.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.S.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-W.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-C.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-G.","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Machin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf002_bb0010","series-title":"Carcinoma Nasopharyngeal. Chemotherapy","first-page":"128","year":"1997"},{"key":"10.1093\/annonc\/mdf002_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/1040-8428(96)00215-6","article-title":"Treatment of head and neck cancer: the role of chemotherapy","volume":"24","author":"Adelstein","year":"1996","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdf002_bb0020","first-page":"5","article-title":"Cancer incidence in Singapore 1993\u20131997","author":"Chia","year":"2000","journal-title":"Singapore Cancer Registry Report No"},{"key":"10.1093\/annonc\/mdf002_bb0025","first-page":"341","article-title":"Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore General Hospital","volume":"25","author":"Fong","year":"1996","journal-title":"Ann Acad Med Singapore"},{"key":"10.1093\/annonc\/mdf002_bb0030","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S","article-title":"Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma","volume":"86","author":"Heng","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf002_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.annonc.a058703","article-title":"A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma","volume":"5","author":"Au","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0040","first-page":"601","article-title":"Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma","volume":"20","author":"Wang","year":"1991","journal-title":"Ann Acad Med Singapore"},{"key":"10.1093\/annonc\/mdf002_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1008255220284","article-title":"Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal carcinoma","volume":"9","author":"Au","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1008390929826","article-title":"Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma","volume":"10","author":"Tan","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0055","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0959-8049(98)00280-9","article-title":"A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma","volume":"34","author":"Yeo","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf002_bb0060","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.1991.9.9.1675","article-title":"Chemotherapy of metastatic and\/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil","volume":"9","author":"Boussen","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1008342828496","article-title":"Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type","volume":"10","author":"Hasbini","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0142(19940115)73:2<247::AID-CNCR2820730203>3.0.CO;2-7","article-title":"A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma","volume":"73","author":"Chi","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf002_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/bjc.1993.312","article-title":"Chemotherapeutic treatment of recurrent and\/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases","volume":"68","author":"Gebbia","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf002_bb0080","first-page":"471","article-title":"Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck","volume":"66","author":"Kish","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdf002_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00002820-199904000-00011","article-title":"Gemcitabine: a pharmacologic and clinical overview [review]","volume":"22","author":"Barton-Burke","year":"1999","journal-title":"Cancer Nurs"},{"key":"10.1093\/annonc\/mdf002_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.annonc.a058910","article-title":"A phase II study of gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0095","unstructured":"WHO. WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48, Geneva: WHO 1979."},{"key":"10.1093\/annonc\/mdf002_bb0100","first-page":"254","article-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"1997"},{"key":"10.1093\/annonc\/mdf002_bb0105","first-page":"45","article-title":"Proportions and their differences. In Altman DG, Machin D, Bryant TN et al. (eds): Statistics with Confidence, 2nd edition. London","author":"Newcombe","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1093\/annonc\/mdf002_bb0110","first-page":"93","article-title":"Time to event studies. In Altman DG, Machin D, Bryant TN et al. (eds): Statistics with Confidence, 2nd edition. London","author":"Machin","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1093\/annonc\/mdf002_bb0115","series-title":"CLINTRIAL\u2122 4 release 4.2 reference guide","author":"Domain Pharma Corporation","year":"1999"},{"key":"10.1093\/annonc\/mdf002_bb0120","unstructured":"SPSS Inc. SPSS\u00ae Base 8.0 for Windows User\u2019s Guide. Chicago, IL: SPSS Inc. 1998."},{"key":"10.1093\/annonc\/mdf002_bb0125","first-page":"565","article-title":"European Organization for Research on Treatment of Cancer. Controlled trials of chemotherapy as an adjuvant or palliative treatment of nasopharyngeal carcinoma","volume":"20","author":"Molinari","year":"1978","journal-title":"IARSC Sci Publ"},{"issue":"Abstr 931","key":"10.1093\/annonc\/mdf002_bb0130","first-page":"20","article-title":"Prognostic model for metastatic nasopharyngeal carcinoma","volume":"233a","author":"Ong","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0135","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.1995.13.10.2594","article-title":"Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study","volume":"13","author":"Loehrer","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a059183","article-title":"Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC)","volume":"6","author":"Crino","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf002_bb0145","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1200\/JCO.2000.18.7.1451","volume":"18","author":"Comella","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341962764X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341962764X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/1\/150\/19479620\/150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:28:11Z","timestamp":1582183691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341962764X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S092375341962764X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf002","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}